If confirmed, the safety review could herald the imposition of restrictions on the use of the antibodies by HHS, which has ...
The move into the UK weight-loss category has been facilitated by the acquisition earlier this year of Zava, a London-based ...
CB1 inhibition is an approach that taps into the body’s natural metabolism to burn fat while preserving muscle for more ...
Fondazione Telethon ETS' Waskyra has become the first gene therapy in the US for patients with Wiskott-Aldrich syndrome (WAS) ...
Technology maturity: Technology has reached a level of maturity that allows integration of various systems and devices to be seamless. Connected health devices and cloud platforms have evolved from ...
The UK government has confirmed that the rebate rate for newer medicines supplied to the NHS under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) will be 14.5% next year, ...
The first CNPV approval falls into the latter category, and is for a US-manufactured version of the widely used antibiotic ...
To address this, Thermo Fisher Scientific now offers Accelerator Drug Development: a suite of integrated services combining CDMO and CRO capabilities to streamline the drug development journey, from ...
Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines. Headquartered in Basel, ...
In another inflection point for the psychedelic medicines category, Mind Medicine (MindMed) has claimed breakthrough status from the FDA for its LSD-based candidate MM120 as a treatment for anxiety.
Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category. Citeline provides intelligence, data, and ...
It's all change at Alphabet's life sciences business Verily, with a $1 billion funding round and a shake-up of its senior leadership, including a new chief executive and executive chairman, who will ...